Related Experiment Videos
Pharmacologic intervention can reestablish baseline hemodynamic parameters during laparoscopy
B W Feig1, D H Berger, T B Dougherty
1Department of Surgical Oncology, UTM.D. Anderson Cancer Center, Houston 77030.
Surgery
|October 1, 1994
Summary
Carbon dioxide (CO2) insufflation during laparoscopy can alter patient physiology. However, with invasive monitoring and nitroglycerin, laparoscopy can be safely performed in patients with heart or lung disease.
Area of Science:
- Cardiovascular Physiology
- Pulmonary Physiology
- Minimally Invasive Surgery
Background:
- Carbon dioxide (CO2) insufflation during laparoscopic surgery can induce significant hemodynamic and pulmonary physiological changes.
- These alterations may pose risks for patients with pre-existing cardiopulmonary conditions.
Purpose of the Study:
- To assess the safety of laparoscopy with CO2 pneumoperitoneum in patients with heart and/or lung disease.
- To determine if invasive monitoring can facilitate early detection and management of physiological changes.
Main Methods:
- Prospective evaluation of 15 patients with pre-existing heart/lung disease undergoing laparoscopy.
- Utilized invasive monitoring to track hemodynamic and pulmonary parameters.
- Administered intravenous nitroglycerin to manage physiological alterations.
Main Results:
- CO2 insufflation led to increased systemic vascular resistance, mean arterial pressure, left ventricular stroke work index, and pulmonary capillary wedge pressure.
- Observed a decrease in cardiac index and oxygen delivery.
- Intravenous nitroglycerin effectively normalized these parameters, with no major complications.
Conclusions:
- Laparoscopy using CO2 pneumoperitoneum can be safely conducted in high-risk patients.
- Appropriate invasive monitoring and timely pharmacologic interventions are crucial for patient safety.